A small company in stealth-mode asked Catalyst to serve as its regulatory team, responsible for building its regulatory strategy from the ground-up, preparing a submission pathway, and requesting/leading key FDA meetings (ex: INTERACT and Pre-IND).
Strategy
Recruited a former FDA OCE (Oncology Center of Excellence) senior leader and reviewer to manage the creation of a go to regulator strategy.
Identified, interviewed, and engaged additional external resources with significant expertise in the disease and technology areas of focus to serve as part of the regulatory team.
Produced a comprehensive Regulatory Information Management System (RIMS) to organize all clinical and regulatory information needed for company submissions to the Agency.
Prepared a submission pathway, timeline, and cost estimate for approval.
Worked with scientific team to prepare to request FDA meetings like INTERACT and Pre-IND meetings.